Devatis Participated in Congresses in Switzerland

Devatis participated in both the Swiss Society of Dermatology and Venereology (SGDV) Congress held in St. Gallen on September 3–5 and the Annual Congress of the Swiss Society of Rheumatology & HPR Symposium in Interlaken on September 4–5. During the events, Devatis met with healthcare professionals from across Switzerland and shared information about its therapeutic portfolio and ongoing activities.

Both congresses brought together participants from different areas of the healthcare sector and provided an environment for professional exchange. On the opening day of the SGDV Congress, Devatis Chairman & CEO Philipp Haas took part in an interview with representatives of Swiss healthcare media.
Since 2018, Devatis has continued its activities in Switzerland with a focus on accessibility, continuity, and collaboration. Participation in these congresses reflects the company’s ongoing presence within the Swiss healthcare market.

For Devatis, congresses and scientific meetings provide opportunities to follow current developments in healthcare and maintain communication with healthcare professionals. Through its participation in these events, the company continued its engagement with stakeholders across the Swiss healthcare community.